Vimarsana
Biggest News Aggregation in the World

Page 3 - Mass Spec News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mass Spec. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mass Spec Today - Breaking & Trending Today

908 Devices Inc. (NASDAQ:MASS) Short Interest Down 9.2% in January - Vimarsana News

908 Devices Inc. (NASDAQ:MASS) Short Interest Down 9.2% in January

908 Devices Inc. (NASDAQ:MASS – Get Free Report) was the target of a large decline in short interest in January. As of January 31st, there was short interest totalling 1,290,000 shares, a decline of 9.2% from the January 15th total of 1,420,000 shares. Currently, 5.5% of the company’s stock are sold short. Based on an […]

Source: wkrb13.com
908 Devices Inc. (NASDAQ:MASS) Sees Significant Drop in Short Interest - Vimarsana News

908 Devices Inc. (NASDAQ:MASS) Sees Significant Drop in Short Interest

908 Devices Inc. (NASDAQ:MASS – Get Free Report) saw a significant decline in short interest in January. As of January 31st, there was short interest totalling 1,290,000 shares, a decline of 9.2% from the January 15th total of 1,420,000 shares. Approximately 5.5% of the company’s stock are short sold. Based on an average trading volume […]

Sumitomo Mitsui Trust Holdings Inc. Has $4.20 Million Holdings in 908 Devices Inc. (NASDAQ:MASS) - Vimarsana News

Sumitomo Mitsui Trust Holdings Inc. Has $4.20 Million Holdings in 908 Devices Inc. (NASDAQ:MASS)

Sumitomo Mitsui Trust Holdings Inc. raised its holdings in shares of 908 Devices Inc. (NASDAQ:MASS – Free Report) by 3.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 629,994 shares of the company’s stock after buying an additional 18,492 […]

QPS Continues UPLCHRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development - Vimarsana News

QPS Continues UPLCHRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development

QPS Holdings LLC QPS a global contract research organization CRO that provides discovery preclinical bioanalysis clinical trials and clinical research services is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics in Europe.

QPS Continues UPLC-HRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development - Vimarsana News

QPS Continues UPLC-HRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development

NEWARK, Del.--(BUSINESS WIRE)--#HRMS--QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials, and clinical research services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics in Europe. QPS annou...